Home

At HAEMATEX, our interest is to develop and provide better laboratory methods for investigating blood clotting and bleeding disorders. Thrombosis and haemorrhage affect many clinical decisions and their control can impact treatment outcomes and indeed life itself. In our view, most coagulation screening tests these days are precise but lack clinical specificity.

Our Australian R&D activity is supported by distributorships for and synergies with selected diagnostic suppliers.  We supply HYPHEN BIOMED products, which include a range of ELISA kits for coagulation research, (autoimmune disease, fibrinolysis and heparinoids are a speciality), kits for antithrombotic agents (including dabigatran and rivaroxaban), materials including clotting factors, antibodies, enzymes, reagents and chromogenic substrates. The HBM facility in Paris is fully ISO certified and most diagnostic products are CE marked.

BIOPORTO products are also distributed by HAEMATEX in Australia. Thus we can supply a range of monoclonal antibodies with potential applications in the coagulation testing area, eg. against von Willebrand factor, antithrombin III and the APC/PCI complex.  BIOPORTO have developed an ELISA kit for this activated protein C/protein C inhibitor  complex which is a reliable marker of  clot activation in vivo and also sepsis. BIOPORTO have products for diabetes and obesity research and also ELISA kits for neutrophil gelatinase-associated lipocalin (NGAL), a marker of acute kidney damage, MBL (mannose binding lectin), deficiency of which is a common cause of  recurrent infections.

XENOMETRIX from Switzerland provide convenient kits for carrying out various Ames tests for mutagenic substances in fluid phase in microplate format. Ideal for assessing new pharmaceuticals, food additives and water testing. Also they have materials and kits for cytotoxicity testing.

HAEMATEX R&D has resulted in a patented method for procoagulant phospholipid (XACT test) which detects microparticles and platelet activation. This low cost method for detecting hypercoagulability has been licensed to a major diagnostic company. We have developed lupus anticoagulant sensitive and LA resistant APTT and dRVVT coagulation reagents in liquid and powder forms. We can supply phospholipids (both native and synthetic), contact activators  and equine collagen for platelet function testing. We are keen to engage in practical R&D with any group seeking to develop new methods, reagents or test kits.

We unreservedly guarantee the quality of all the products which we distribute and manufacture and offer competitive prices.